Sevelamer Carbonate Tablet, Film Coated
Product Images NDC 76282-407

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Sevelamer Carbonate (NDC 76282-407). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Exelan Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Sevelamer Carbonate Tabs 800mg)

This is a description of Sevelamer carbonate tablets with the usual dosage guidelines provided and a list of inactive ingredients. The tablets come in a container that should be protected from moisture and stored at room temperature as defined by the USP. They are manufactured by Exelan Pharmaceuticals and distributed by InvaGen Pharmaceuticals.*

FDA Label Image

Chemical Structure/figure 1 (Sevelamer Carbonate Tabs Fig01)

This appears to be a chemical formula consisting of nitrogen and oxygen atoms with attached hydrogen atoms. The compound might potentially be an amino acid, but without additional information, the specific identity and properties of the compound cannot be determined.*

FDA Label Image

Figure 2 (Sevelamer Carbonate Tabs Fig02)

This appears to be a chart or graph displaying data on the reduction of serum phosphorus levels in patients using Sevelamer Hydrochloride compared to an active control. It shows the percentage of patients who experienced improvement from baseline, as well as a reduction in serum phosphorus levels. The chart also includes an X-axis indicating a reduction factor and a Y-axis indicating the percentage of patients.*

FDA Label Image

Figure 3 (Sevelamer Carbonate Tabs Fig03)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.